Results 111 to 120 of about 3,844 (196)

Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis

open access: yesJournal of Neuroinflammation, 2006
Background In meningitis, the cerebrospinal fluid contains high levels of innate immune molecules (e.g. complement) which are essential to ward off the infectious challenge and to promote the infiltration of phagocytes (neutrophils, monocytes).
Gasque Philippe   +2 more
doaj   +1 more source

Characterization of CD46 and β1 integrin dynamics during sperm acrosome reaction

open access: yesScientific Reports, 2016
The acrosome reaction (AR) is a process of membrane fusion and lytic enzyme release, which enables sperm to penetrate the egg surroundings. It is widely recognized that specific sperm proteins form an active network prior to fertilization and their ...
M. Frolikova   +3 more
semanticscholar   +1 more source

Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP). [PDF]

open access: bronze, 1997
Carmen W. van den Berg   +3 more
openalex   +1 more source

CD46 Null Packaging Cell Line Improves Measles Lentiviral Vector Production and Gene Delivery to Hematopoietic Stem and Progenitor Cells

open access: yesMolecular Therapy: Methods & Clinical Development, 2019
Lentiviral vectors (LVs) pseudotyped with the measles virus hemagglutinin (H) and fusion (F) glycoproteins have been reported to more efficiently transduce hematopoietic stem and progenitor cells (HSPCs) compared with vesicular stomatitis virus ...
Stosh Ozog   +7 more
doaj  

Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic

open access: yesMolecular Therapy: Methods & Clinical Development, 2016
Rituximab is a mouse/human chimeric monoclonal antibody targeted toward CD20. It is efficient as first-line therapy of CD20-positive B-cell malignancies. However, a large fraction of treated patients relapse with rituximab-resistant disease. So far, only
Maximilian Richter   +13 more
doaj   +1 more source

CD46 Protects against Chronic Obstructive Pulmonary Disease

open access: yesPLoS ONE, 2011
Chronic obstructive pulmonary disease and emphysema develops in 15% of ex-smokers despite sustained quitting, while 10% are free of emphysema or severe lung obstruction. The cause of the incapacity of the immune system to clear the inflammation in the first group remains unclear.We searched genes that were protecting ex-smokers without emphysema, using
Grumelli, Sandra   +4 more
openaire   +5 more sources

Periferal Lökositlerde CD35, CD46, CD55 ve CD59 Düzeyleri

open access: yesGenel Tıp Dergisi, 2017
Giriş: Kompleman aktivasyonunun, hedef molekül dışında bulunan çevre dokulara zarar vermesini kompleman düzenleyici proteinler engeller. Özellikle CD35, CD46, CD55 ve CD59 hastalıklarla ilişkilendirilen kompleman düzenleyici proteinlerdir.
Aydan Karagül   +3 more
doaj  

Soluble CD46 as a diagnostic marker of hepatic steatosis

open access: yeseBioMedicine
Background The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) incurs substantial morbidity, mortality and healthcare costs. Detection and clinical intervention at early stages of disease improves prognosis; however, we are currently limited by a lack of reliable diagnostic tests for population screening and ...
Bitterer, Florian   +15 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy